Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes (Q28728799)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: 16 June 2010)
edit
Language Label Description Also known as
English
Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes
scientific article (publication date: 16 June 2010)

    Statements

    Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes (English)
    0 references
    0 references
    0 references
    Travis T Wager
    0 references
    Ramalakshmi Y Chandrasekaran
    0 references
    Xinjun Hou
    0 references
    Matthew D Troutman
    0 references
    Patrick R Verhoest
    0 references
    Anabella Villalobos
    0 references
    Yvonne Will
    0 references
    16 June 2010
    0 references
    1
    0 references
    6
    0 references
    420-34
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit